BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 30883607)

  • 1. RNAi-based small molecule repositioning reveals clinically approved urea-based kinase inhibitors as broadly active antivirals.
    Lesch M; Luckner M; Meyer M; Weege F; Gravenstein I; Raftery M; Sieben C; Martin-Sancho L; Imai-Matsushima A; Welke RW; Frise R; Barclay W; Schönrich G; Herrmann A; Meyer TF; Karlas A
    PLoS Pathog; 2019 Mar; 15(3):e1007601. PubMed ID: 30883607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient Inhibition of Avian and Seasonal Influenza A Viruses by a Virus-Specific Dicer-Substrate Small Interfering RNA Swarm in Human Monocyte-Derived Macrophages and Dendritic Cells.
    Jiang M; Österlund P; Westenius V; Guo D; Poranen MM; Bamford DH; Julkunen I
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30463970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide RNAi screen for viral replication in mammalian cell culture.
    Prusty BK; Karlas A; Meyer TF; Rudel T
    Methods Mol Biol; 2011; 721():383-95. PubMed ID: 21431699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Verdinexor, a novel selective inhibitor of nuclear export, reduces influenza a virus replication in vitro and in vivo.
    Perwitasari O; Johnson S; Yan X; Howerth E; Shacham S; Landesman Y; Baloglu E; McCauley D; Tamir S; Tompkins SM; Tripp RA
    J Virol; 2014 Sep; 88(17):10228-43. PubMed ID: 24965445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptomic characterization of the novel avian-origin influenza A (H7N9) virus: specific host response and responses intermediate between avian (H5N1 and H7N7) and human (H3N2) viruses and implications for treatment options.
    Josset L; Zeng H; Kelly SM; Tumpey TM; Katze MG
    mBio; 2014 Feb; 5(1):e01102-13. PubMed ID: 24496798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA hsa-miR-324-5p Suppresses H5N1 Virus Replication by Targeting the Viral PB1 and Host CUEDC2.
    Kumar A; Kumar A; Ingle H; Kumar S; Mishra R; Verma MK; Biswas D; Kumar NS; Mishra A; Raut AA; Takaoka A; Kumar H
    J Virol; 2018 Oct; 92(19):. PubMed ID: 30045983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small molecule inhibitors of the c-Jun N-terminal kinase (JNK) possess antiviral activity against highly pathogenic avian and human pandemic influenza A viruses.
    Nacken W; Ehrhardt C; Ludwig S
    Biol Chem; 2012 May; 393(6):525-34. PubMed ID: 22628315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of pyrrolo[3,2-c]pyridin-4-amine compounds as a new class of entry inhibitors against influenza viruses in vitro.
    Chang SY; Cruz DJ; Ko Y; Min JY
    Biochem Biophys Res Commun; 2016 Sep; 478(4):1594-601. PubMed ID: 27586275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide RNAi screen identifies human host factors crucial for influenza virus replication.
    Karlas A; Machuy N; Shin Y; Pleissner KP; Artarini A; Heuer D; Becker D; Khalil H; Ogilvie LA; Hess S; Mäurer AP; Müller E; Wolff T; Rudel T; Meyer TF
    Nature; 2010 Feb; 463(7282):818-22. PubMed ID: 20081832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repurposing Kinase Inhibitors as Antiviral Agents to Control Influenza A Virus Replication.
    Perwitasari O; Yan X; O'Donnell J; Johnson S; Tripp RA
    Assay Drug Dev Technol; 2015 Dec; 13(10):638-49. PubMed ID: 26192013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. pH Optimum of Hemagglutinin-Mediated Membrane Fusion Determines Sensitivity of Influenza A Viruses to the Interferon-Induced Antiviral State and IFITMs.
    Gerlach T; Hensen L; Matrosovich T; Bergmann J; Winkler M; Peteranderl C; Klenk HD; Weber F; Herold S; Pöhlmann S; Matrosovich M
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28356532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral activity of the proteasome inhibitor VL-01 against influenza A viruses.
    Haasbach E; Pauli EK; Spranger R; Mitzner D; Schubert U; Kircheis R; Planz O
    Antiviral Res; 2011 Sep; 91(3):304-13. PubMed ID: 21777621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The C-Terminal Tail of TRIM56 Dictates Antiviral Restriction of Influenza A and B Viruses by Impeding Viral RNA Synthesis.
    Liu B; Li NL; Shen Y; Bao X; Fabrizio T; Elbahesh H; Webby RJ; Li K
    J Virol; 2016 May; 90(9):4369-4382. PubMed ID: 26889027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A small molecule multi-kinase inhibitor reduces influenza A virus replication by restricting viral RNA synthesis.
    Martinez-Gil L; Alamares-Sapuay JG; Ramana Reddy MV; Goff PH; Premkumar Reddy E; Palese P
    Antiviral Res; 2013 Oct; 100(1):29-37. PubMed ID: 23891991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in Type I interferon response in human lung epithelial cells infected by highly pathogenic H5N1 and low pathogenic H11N1 avian influenza viruses.
    Thube MM; Shil P; Kasbe R; Patil AA; Pawar SD; Mullick J
    Virus Genes; 2018 Jun; 54(3):414-423. PubMed ID: 29574656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repurposing of Drugs as Novel Influenza Inhibitors From Clinical Gene Expression Infection Signatures.
    Pizzorno A; Terrier O; Nicolas de Lamballerie C; Julien T; Padey B; Traversier A; Roche M; Hamelin ME; Rhéaume C; Croze S; Escuret V; Poissy J; Lina B; Legras-Lachuer C; Textoris J; Boivin G; Rosa-Calatrava M
    Front Immunol; 2019; 10():60. PubMed ID: 30761132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influenza Virus Infections and Cellular Kinases.
    Meineke R; Rimmelzwaan GF; Elbahesh H
    Viruses; 2019 Feb; 11(2):. PubMed ID: 30791550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of Clade-Specific and Broadly Reactive Live Attenuated Influenza Virus Vaccines against Rapidly Evolving H5 Subtype Viruses.
    Boonnak K; Matsuoka Y; Wang W; Suguitan AL; Chen Z; Paskel M; Baz M; Moore I; Jin H; Subbarao K
    J Virol; 2017 Aug; 91(15):. PubMed ID: 28490598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Network-Guided Discovery of Influenza Virus Replication Host Factors.
    Ackerman EE; Kawakami E; Katoh M; Watanabe T; Watanabe S; Tomita Y; Lopes TJ; Matsuoka Y; Kitano H; Shoemaker JE; Kawaoka Y
    mBio; 2018 Dec; 9(6):. PubMed ID: 30563907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of nuclear NS1 protein in highly pathogenic H5N1 influenza viruses.
    Mok BW; Liu H; Chen P; Liu S; Lau SY; Huang X; Liu YC; Wang P; Yuen KY; Chen H
    Microbes Infect; 2017 Dec; 19(12):587-596. PubMed ID: 28903072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.